WHO’s Working for Health 2022–2030 Action Plan

By Staff Writer

February 6, 2023

Introduction:

Achieving universal health care (UHC) is a World Health Organisation (WHO) strategic priority, with the goal of 1 billion more people benefitting from universal health coverage by 2025. This publication on health and care workforce planning provides a rationale for the related actions of the Working for Health progression model.

The Need for Planning and Financing:

Planning and financing are integral to the efficient and cost-effective development of health and care workforce policies. Their importance is particularly evident in low- and middle-income countries (LMICs), where technical and institutional capacity to support planning and financing is often inadequate. In such strained economic environments, building this capacity is a priority.

The Working for Health Model:

The Working for Health progression model offers a pathway for countries facing critical workforce challenges to progressively optimise, build, and strengthen their workforce. The model focuses on three key themes: planning and financing, education and employment, and protection and performance.

The Current Context:

The COVID-19 pandemic has highlighted the need for effective planning and strategic financing in the health and care workforce. LMICs face challenges such as building labour market demand for health and care workers, mobilising sufficient and sustainable revenue, and attracting and retaining workers within the health system.

Policy Landscape:

The WHO Global Strategy presents a range of policy options to advance the health and care workforce agenda. These options emphasise the need to strengthen the integration and synergy of health workforce policy with broader development strategies.

Challenges:

The COVID-19 pandemic has had a devastating impact on economies worldwide. Financial resources allocated to health and care workforce are constrained by the economic crises facing many countries. In addition, many countries lack the technical and institutional capacity to translate evidence-based information into policy development and implementation.

Future Directions:

The challenges faced by the health and care workforce require strategic planning and financing. Investment in the health and care workforce is critical in emergency and disaster risk management, building the resilience of the health system to shocks and surges in demand.

Conclusion:

The health and care workforce is a vital component of the healthcare ecosystem. As such, it is essential to invest in strategic planning and financing to ensure its growth and sustainability. By doing so, we can ensure a resilient health system capable of meeting the needs of populations worldwide.

 

 

Reference url

Recent Posts

allopurinol Marfan syndrome orphan
       

Allopurinol Designated an Orphan Drug for Marfan Syndrome

🌟 What does the EMA’s orphan drug designation for allopurinol mean for those impacted by Marfan syndrome?

This groundbreaking move highlights a significant step forward in tackling rare diseases, offering hope to patients with limited treatment options. Allopurinol, traditionally used for gout, shows promise in addressing life-threatening aortic complications associated with Marfan syndrome, thanks to its antioxidant properties.

Dive into the implications of this development for healthcare innovation, patient access, and the future of rare disease treatment!

#SyenzaNews #HealthEconomics #Innovation #MarketAccess

marstacimab hemophilia B
                

NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment Landscapes and Economic Implications

💡 Are we witnessing a paradigm shift in hemophilia treatment?

The recent recommendation from NICE for marstacimab as a novel therapy for severe hemophilia B is a game-changer. With its ability to provide effective prophylaxis while potentially lowering treatment costs, this could reshape patient care and health economics in this space.

Dive into the implications this has for patients and healthcare providers, and why marstacimab’s approval could be a pivotal moment for hemophilia management.

Explore the full article for deeper insights!

#SyenzaNews #HealthEconomics #HealthcareInnovation #MarketAccess

HPV-related cancer trends
    

HPV-Related Cancer Trends in South Africa 2011-2021

🌍 Are we witnessing a rise in HPV-related cancer in South Africa?

A recent analysis of data from the South African National Cancer Registry highlights concerning trends: while cervical cancer rates are declining, there’s an alarming rise in non-cervical anogenital cancers. This underscores the urgent need for enhanced cancer prevention and access to efficient healthcare services in the country.

Dive into the findings and explore the implications for health systems and policies.

#SyenzaNews #HealthEconomics #HealthcareInnovation #GlobalHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.